首页> 外文期刊>Molecules >Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability
【24h】

Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability

机译:固体药物输送系统配方对水溶性差的药物溶解度和渗透性的影响

获取原文
           

摘要

The majority of drugs have a low dissolution rate, which is a limiting step for their absorption. In this manuscript, solid dispersions (SD), solid self-microemulsifying drug delivery systems (S-SMEDDS) and solid self-nanoemulsifying drug delivery systems (S-SNEDDS) were evaluated as potential formulation strategies to increase the dissolution rate of carbamazepine. Influence of increased dissolution rate on permeability of carbamazepine was evaluated using PAMPA test. In S-SMEDDS and S-SNEDDS formulations, the ratio of liquid SMEDDS/SNEDDS and solid carrier (Neusilin® UFL2) was varied, and carbamazepine content was constant. In SD formulations, the ratio of carbamazepine and Neusilin® UFL2, was varied. Formulations that showed the best dissolution rate of carbamazepine (SD_1:6, SMEDDS_1:1, SNEDDS_1:6) were mutually compared, characterization of these formulations was performed by DSC, PXRD and FT-IR analyses, and a PAMPA test was done. All formulations have shown a significant increase in dissolution rate compared to pure carbamazepine and immediate-release carbamazepine tablets. Formulation S-SMEDDS_1:1 showed the fastest release rate and permeability of carbamazepine. DSC, PXRD and FT-IR analyses confirmed that in S-SMEDDS and S-SNEDDS carbamazepine remained in polymorph form III, and that it was converted to an amorphous state in SD formulations. All formulations showed increased permeability of carbamazepine, compared to pure carbamazepine.
机译:大多数药物的溶出度低,这是其吸收的限制步骤。在本手稿中,评估了固体分散体(SD),固体自微乳化药物输送系统(S-SMEDDS)和固体自微乳化药物输送系统(S-SNEDDS)作为提高卡马西平溶解率的潜在配方策略。使用PAMPA测试评估溶出度增加对卡马西平渗透性的影响。在S-SMEDDS和S-SNEDDS配方中,液体SMEDDS / SNEDDS与固体载体(Neusilin ® UFL2)的比率是变化的,卡马西平的含量是恒定的。在SD配方中,卡马西平和Neusilin ® UFL2的比例有所不同。相互比较显示最佳卡马西平溶解度的制剂(SD_1:6,SMEDDS_1:1,SNEDDS_1:6),通过DSC,PXRD和FT-IR分析对这些制剂进行表征,并进行PAMPA测试。与纯卡马西平和速释卡马西平片剂相比,所有制剂均显示出溶出度的显着提高。制剂S-SMEDDS_1:1显示了卡马西平的最快释放速率和渗透性。 DSC,PXRD和FT-IR分析证实,卡马西平在S-SMEDDS和S-SNEDDS中保留为多晶型物形式III,并且在SD制剂中已转变为非晶态。与纯卡马西平相比,所有制剂均显示出卡马西平的渗透性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号